04.04.2016 • NewsBayerGELanxess

Gnann succeeds Hartel to Lead Wacker Silicones

Dr. Robert Gnann (51) has taken over as president of Wacker Chemie AG’s...
Dr. Robert Gnann (51) has taken over as president of Wacker Chemie AG’s WACKER SILICONES division effective April 1, 2016. (Photo: Wacker Chemie AG)

Dr. Robert Gnann (51) has taken over as president of Wacker Silicones effective April 1, 2016. He succeeds Dr. Christian Hartel, who was appointed to the Wacker Group’s Executive Board in early November 2015. Gnann comes to Wacker from Momentive Performance Materials, where he headed the chemical company’s elastomer and European activities.

After studying chemistry at the University of Cologne, Germany, and earning his doctorate, Robert Gnann began his career at GE Silicones in the USA in 1996. He then moved on to Bayer and Lanxess in Canada and Germany, where he held managerial positions in such areas as production and technology. From 2008, Gnann was responsible for the elastomers business unit at Momentive Performance Materials and, in 2010, additionally took charge of the company’s European activities.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read